Skip to main content

Table 1 Demographic, risk factor, clinical characteristics, and LOH frequency of ESCC patients (N = 26)

From: Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array

No. ID Age/sex Tumor location Tumor stage/grade Metastasis FH of UGI cancer (Y/N) Tobacco use (Y/N) Alcohol use (Y/N) Pickled vegetables (Y/N) Survival status Survival months LOH* (blood DNA reference) LOH* (normal esophagus reference)
1 SHE0043 72/M lower 3/II Y N Y N N deceased 29.6 0.951  
2 SHE0133 55/M lower 1/III Y Y Y N N deceased 36.5 0.907  
3 SHE0200 46/M middle 1/III Y Y Y Y Y deceased 45 0.875  
4 SHE0204 51/M middle 2/III N Y Y N N alive 64.9 0.345  
5 SHE0223 60/M middle 2/III N Y N N Y deceased 34.8 0.807  
6 SHE0297 64/M middle 4/III Y Y Y Y N deceased 6.9 0.596  
7 SHE0362 52/M middle 2/I Y Y Y Y Y alive 58.1 0.236  
8 SHE0366 46/M lower 3/II Y N Y Y N deceased 26.2 0.849  
9 SHE0633 63/M lower 3/III N Y Y N Y deceased 26.5 0.635  
10 SHE0758 54/M lower 3/III N N Y N N deceased 6.6 0.267  
11 SHE0782 49/F middle 2/II Y Y N N Y deceased 29.6 0.211  
12 SHE0816 58/M upper 3/III N Y Y Y Y deceased 30.7 0.262  
13 SHE0832 52/M middle 3/II N Y Y Y Y alive 42.5 0.215 0.219
14 SHE0848 62/F middle 3/II N N Y N Y alive 39.0 0.384  
15 SHE0863 51/M upper 3/II N N Y Y Y alive 39.4 0.567  
16 SHE0864 55/M middle 4/II Y N Y Y Y deceased 10.8 0.204 0.197
17 SHE0878 67/M lower 3/I N Y Y Y Y deceased 2.2 0.806  
18 SHE0905 58/F middle 3/II N N N N Y alive 35.5 0.188  
19 SHE0912 45/M middle 3/II Y N Y N Y deceased 31.2 0.747  
20 SHE0921 64/M lower 3/III N Y Y Y Y deceased 13.2 0.246  
21 SHE1255 61/M middle 2/II Y Y N Y Y deceased 20.0 0.567  
22 SHE1264 68/M middle 3/II Y N Y Y N deceased 16.2 0.27 0.267
23 SHE1301 64/M middle 3/II Y Y N N Y alive 23.2 0.233  
24 SHE1310 55/F middle 2/II Y N N N Y unknown - 0.593  
25 SHE1408 63/M middle 3/II N N Y Y N deceased 23.3 0.224  
26 SHE1490 52/M middle 3/II N N Y Y Y alive 20.0 0.3 0.287